Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Chlorhexidine dihydrochloride, Lidocaine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
FOR. Covonia Lozenges Menthol is a compressed lozenge for local action in the mouth and the pharynx. It is an antiseptic and local pain-killer. Covonia Lozenges Menthol is recommended for:
E COVONIA LOZENGES MENTHOL. Do not use Covonia Lozenges Menthol
Children Do not use this medicine on children younger than 12 years old. Other medicines and Covonia Lozenges Menthol Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Turn over
92795122103 30403215-2
3. HOW TO TAKE CO Always use Covonia doctor has told you. Check with your doc This medicine must Consult a doctor, if y improve after 3 to 4 The recommended Adults: 6 to 10 lozen Allow the lozenge to Use in children and Children from 12 ye Warning: Do not ta leaflet tells you to. If you use more Co you should This medicine conta If used appropriately small. Symptoms of tinnitus, breathing d rhythm, reduced co If you forget to use No special precautio If you stop using C No special precautio If you have further q ask your doctor or p
4. POSSIBLE SIDE E Like all medicines, C cause side effects, a
Product Title: Covonia Medicated Sore Throat 5mg/1mg Lozenges Menthol Flavour Pack Size: 36's 92795122103_36's_PIL Mat.No: younger children than 297 x 148mm
Dimensions: onia Lozenges Menthol stKeyline if you are Ref:using, have any other medicines. Barcode: ously with other disinfectants. ol and food and drink Pharmacode: ded. Datamatrix: ding t-feeding, think you might Reason for Change: to have a baby, ask your Update active name taking this medicine. to Lidocaine Hydrochloride Monohydrate. utions are respected, can be used during ng.1. Colour: Black are using this medicine. Keyline (Non-Printing) 2. Colour: nes ded. Cirrus_Info_Box 3. Colour: ol contains Levomenthol 4. Colour:
contains levomenthol; be 5. Colour: who have a history of 6. Menthol Colour: contains ges e Sorbitol 7. Colour:is a source of told you that you or your Colour: an8.intolerance to some agnosed with hereditary 9. Colour: rare genetic disorder in k 10.Colour: down fructose, contact our11.Colour: child take or receive itol may cause mild 12.Colour: and have a mild laxative 2.6Kcal/g sorbitol. Helvetica Neue LT Std 1. Fonts Used: Point Size Used: Min:8.5pt
Max: 8.5pt
2. Fonts Used: Point Size Used: Min:
Max:
COVONIA LOZENGES MENTHOL. Always use Covonia Lozenges Menthol exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. This medicine must not be used for long periods. Consult a doctor, if your symptoms worsen or do not improve after 3 to 4 days. The recommended dose is: Adults: 6 to 10 lozenges per day. Allow the lozenge to melt in the mouth slowly. Use in children and adolescents Children from 12 years old: 3 to 5 lozenges per day. Warning: Do not take more medicine than the leaflet tells you to. If you use more Covonia Lozenges Menthol than you should This medicine contains only a fraction of the toxic dose. If used appropriately the risks of an overdose are very small. Symptoms of an overdose are: restlessness, tinnitus, breathing difficulties, disruption of the cardiac rhythm, reduced control on the swallowing reflex. If you forget to use Covonia Lozenges Menthol No special precautions needed. If you stop using Covonia Lozenges Menthol No special precautions needed. If you have further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Covonia Lozenges Menthol can cause side effects, although not everybody gets them.
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
COVONIA LOZENGES MENTHOL Keep this medicine out of the sight and reach of children. Store below 25°C. Do not use Covonia Lozenges Menthol after the expiry date which is stated on the box/blister after "EXP". The first two figures indicate the month, the following two or four figures the year. The expiry date refers to the last day of that month.
What Covonia Lozenges Menthol contains
3. Fonts Used: Point Size Used: Min:
Max:
4. Fonts Used: Point Size Used: Min:
Max:
5. Fonts Used: Point Size Used: Min:
Max:
Proof Number: 1 Date: 16.03.2021 Operator: ECA Artwork Number: 1203097 Suffix: F CRN: 18222 Local Authority submission required: Yes Approved by: Date:
92795122103
The active substance in Covonia Medicated Sore Throat 5mg/1mg Lozenges Menthol Flavour is chlorhexidine dihydrochloride, lidocaine hydrochloride.
Medicines with the same active substance, strength and form include: Covonia Medicated Sore Throat 5mg/1mg Lozenges Lemon Flavour. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Covonia Medicated Sore Throat 5mg/1mg Lozenges Menthol Flavour, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Symptomatic and local treatment at the pharynx. Proposed as disinfectant and local pain-killer of sore throat and disorders of the pharynx and mouth accompanied by irritation. The presence of lidocaine causes a quick alleviation of the symptoms.
In case of a bacterial infection accompanied by fever, a supplementary treatment is required.
Covonia Lozenges Menthol is sugar free and can therefore also be used in diabetic patients.
Posology
Adults: 6 to 10 tablets per day, to melt slowly in the mouth.
Children from 12 years old: half dose.
This medicine is intended as symptomatic treatment and should not be used on a long-term basis. If there is no improvement within 3 to 4 days of treatment, it is advisable to consult a doctor.
Method of administration
Oromucosal use
Children younger than 12 years old.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, and in particular to local anaesthetics such as lidocaine.
Disinfecting substances do not make sterile; they temporarily reduce the number of micro- organisms at the oral cavity and pharynx.
Restrict the use of this medicine to the necessary alleviation of the existing pain and irritation. It must not be administered on a long term basis, in an uninterrupted or repeated manner.
In view of the presence of levomenthol, caution should be taken when using on young children if there is a history of convulsions.
Avoid the use of this medicine in persons with extreme allergic predisposition.
The use of a too high dose (more than 20 tablets per day) can cause a small risk on too great insensitivity of the glottis area, which can cause a diminished control on the swallowing reflex and food aspiration in the airways can occur.
Covonia Lozenges Menthol contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
The additive effect of concomitantly administered products containing sorbitol (fructose) and dietary intake of sorbitol (fructose) should be taken into account.
The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly.
Due to possible interferences (opposite action or inactivation) the simultaneous or consecutive use of antiseptics should be avoided.
Pregnancy
There are no or limited amount of data from the use of lidocaine and chlorhexidine in pregnant women. Animal studies do not indicate reproductive toxicity (see section 5.3).
The use of Covonia Lozenges Menthol may be considered during pregnancy, if necessary.
Breast-feeding
Lidocaine is excreted in breast milk but in small quantities that there is generally no risk of the infant being affected at therapeutic dose levels. There is no data on excretion of chlorhexidine in breast milk. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Covonia Lozenges Menthol therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Fertility
There are no relevant data on human fertility available. Animal data with lidocaine does not indicate an effect on male fertility in rats. Animal data with chlorhexidine suggests depression of ovarian activity in mice. The relevance of these finding to humans is not known however are limited given the local exposure to the patient with Covonia Lozenges Menthol.
The use of Covonia Lozenges Menthol has no influence on the ability to drive and use machines.
Side effects are classified according to organ system with evaluation of the frequency according to the following convention: very common (≥ 1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1000, < 1/100), rare (≥ 1/10000, < 1/1000), very rare (<1/10000), not known (cannot be estimated from the available data).
Nervous System Disorders
Common: Oral paraesthesia/hypoaesthesia
Immune system disorders (frequency not known)
It should be taken into account that rare allergic reactions of the skin and mucous membrane, which are caused by contact with anaesthetics of the amide-type, such as lidocaine can occur: cases of dermatitis and rashes, which were caused by this product in other circumstances, have been described.
Anaphylactic reactions may occur.
General disorders and administration site conditions (frequency not known)
Taste disorders and a burning feeling on the tongue may occur.
Prolonged and continuous use of chlorhexidine can cause brown-discoloration of the teeth. However, this brown-discoloration is removable.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard or search for “MHRA Yellow Card” in the Google Play or Apple App Store.
Although this medicine contains only a fraction of the toxic dose and although the foreseen use of this composed medicine is limited to local use, the possibility of an overdose by mistake or carelessness should be taken into account, especially in children.
Symptoms of intoxication:
Lidocaine can cause a systematic intoxication (toxic dose for adults from 0.5 g onwards), which affects the central nervous system and the cardiovascular system.
restlessness, yawning, nervousness, tinnitus, nystagmus, muscle tremor, convulsions, depression, dyspnea.
reduced contractility of the heart muscle, peripheral vasodilation, hypotension, bradycardia, disturbed cardiac rhythm, cardiac arrest.
Chlorhexidine is resorbed in very little amounts from the gastrointestinal tract.
Antidote: none.
Treatment:
Systemic intoxication:
Immediately stop the intake of the medicine.
Hospitalization to ensure the respiration, to counteract dehydration and to maintain the blood circulation.
In case of seizures: diazepam
Choking:
Clear the airways, application of the Heimlich-manoeuvre.
If the obstruction persists, hospitalize the patient.
Ask anything about Covonia Medicated Sore Throat 5mg/1mg Lozenges Menthol Flavour. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.